MI Medical Innovation GmbH
Aschaffenburg
About MI Medical Innovation GmbH
MI is engaged in medical device probe and implant developments, Hyper-IMS patents at MI, regulatory under umbrella of CGS sensors. It has been awarded a Horizon 2020 SME Instrument phase 1 grant from the European Commission to develop Sniff-Nose for clinical assessment of heart failure. MI is a concept company to give a platform to new ideas under constraints of correct medical device regulatory. The joint project proposed together with our French partner, emka TECHNOLOGIES, got granted with Horizon 2020 Seal of Excellence, issued by the European Commission on 8 February 2016.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $56.5K
- Last round: Grant (Sep 2015)
- Website: mi-innovation.com
- Phone: +49 (0)6021 / 4434522
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/mi-medical-innovation-gmbh-1618340 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.